This video explains 10 early signs and symptoms of diabetes that often go unnoticed. These include increased thirst, frequent bathroom breaks, recurrent infections, unexplained weight changes, and blurry…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…
NEW YORK (Reuters Health) – In patients with high-risk acute coronary syndromes (ACS) without ST-segment elevation, delaying intervention until the next working day does not appear to pose…
NEW YORK (Reuters Health) – A low-carbohydrate, Mediterranean-style diet is more effective than a conventional low-fat, calorie restricted diet for patients with type II diabetes, according to results…
NEW YORK (Reuters Health) – Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed type 2 diabetes,…
In one of the longest-term randomized trials of its kind, researchers compared the effects of a Mediterranean-style diet versus a typical low-fat diet for diabetes management. The trial…
NEW YORK (Reuters Health) – Prior research has linked the thiazolidinediones pioglitazone and rosiglitazone with an increased risk of heart failure, myocardial infarction, and death, but new research…
NEW YORK (Reuters Health) – Although spontaneous reperfusion during percutaneous angiography for treatment of ST-segment myocardial infarction (STEMI) occurs less often in patients with diabetes than in nondiabetics,…
NEW YORK (Reuters Health) – In a study of childhood cancer survivors, treatment with total body or abdominal irradiation was associated with an increased risk of diabetes later…
NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less…
NEW YORK (Reuters Health) – The well-known association between poor glycemic control and low HDL cholesterol in patients with type 2 diabetes is independent of obesity and hypertriglyceridemia,…
NEW YORK (Reuters Health) – Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetes, new research shows. By contrast, treatment with…